An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
- PMID: 24032382
- PMCID: PMC5803655
- DOI: 10.1164/rccm.201308-1483ST
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
Abstract
Background: In 2002 the American Thoracic Society/European Respiratory Society (ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, and provided standardized terminology and diagnostic criteria. In addition, the historical "gold standard" of histologic diagnosis was replaced by a multidisciplinary approach. Since 2002 many publications have provided new information about IIPs.
Purpose: The objective of this statement is to update the 2002 ATS/ERS classification of IIPs.
Methods: An international multidisciplinary panel was formed and developed key questions that were addressed through a review of the literature published between 2000 and 2011.
Results: Substantial progress has been made in IIPs since the previous classification. Nonspecific interstitial pneumonia is now better defined. Respiratory bronchiolitis-interstitial lung disease is now commonly diagnosed without surgical biopsy. The clinical course of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia is recognized to be heterogeneous. Acute exacerbation of IIPs is now well defined. A substantial percentage of patients with IIP are difficult to classify, often due to mixed patterns of lung injury. A classification based on observed disease behavior is proposed for patients who are difficult to classify or for entities with heterogeneity in clinical course. A group of rare entities, including pleuroparenchymal fibroelastosis and rare histologic patterns, is introduced. The rapidly evolving field of molecular markers is reviewed with the intent of promoting additional investigations that may help in determining diagnosis, and potentially prognosis and treatment.
Conclusions: This update is a supplement to the previous 2002 IIP classification document. It outlines advances in the past decade and potential areas for future investigation.
Figures









Similar articles
-
Rare idiopathic intestinal pneumonias (IIPs) and histologic patterns in new ATS/ERS multidisciplinary classification of the IIPs.Eur J Radiol. 2015 Mar;84(3):542-546. doi: 10.1016/j.ejrad.2014.11.032. Epub 2014 Dec 22. Eur J Radiol. 2015. PMID: 25591580
-
American Thoracic Society-European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 2002.Radiographics. 2015 Nov-Dec;35(7):1849-71. doi: 10.1148/rg.2015140334. Epub 2015 Oct 9. Radiographics. 2015. PMID: 26452110
-
Idiopathic interstitial pneumonias: a radiology-pathology correlation based on the revised 2013 American Thoracic Society-European Respiratory Society classification system.Curr Probl Diagn Radiol. 2015 Jan-Feb;44(1):15-25. doi: 10.1067/j.cpradiol.2014.07.005. Epub 2014 Nov 11. Curr Probl Diagn Radiol. 2015. PMID: 25512168 Review.
-
Idiopathic interstitial pneumonias: review of the latest American Thoracic Society/European Respiratory Society classification.Radiol Bras. 2018 Sep-Oct;51(5):321-327. doi: 10.1590/0100-3984.2016.0134. Radiol Bras. 2018. PMID: 30369660 Free PMC article.
-
Changes in the current classification of IIP: A critical review.Respirology. 2015 Jul;20(5):699-704. doi: 10.1111/resp.12553. Epub 2015 May 26. Respirology. 2015. PMID: 26011188 Review.
Cited by
-
Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases.J Bras Pneumol. 2021 May 31;47(3):e20200096. doi: 10.36416/1806-3756/e20200096. eCollection 2021. J Bras Pneumol. 2021. PMID: 34076172 Free PMC article.
-
Exposure to PM2.5 is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case-control study.Respir Res. 2021 Mar 12;22(1):80. doi: 10.1186/s12931-021-01671-6. Respir Res. 2021. PMID: 33711988 Free PMC article.
-
Programmed cell death 1 (PD-1)/PD-ligand 1(PD-L1) inhibitors-related pneumonitis in patients with advanced non-small cell lung cancer.Asia Pac J Clin Oncol. 2020 Dec;16(6):299-304. doi: 10.1111/ajco.13380. Epub 2020 Aug 5. Asia Pac J Clin Oncol. 2020. PMID: 32757454 Free PMC article. Review.
-
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data.Ann Am Thorac Soc. 2024 Mar;21(3):428-437. doi: 10.1513/AnnalsATS.202305-491OC. Ann Am Thorac Soc. 2024. PMID: 38134434 Free PMC article.
-
Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples.Mol Cell Proteomics. 2016 Sep;15(9):3017-29. doi: 10.1074/mcp.M116.060764. Epub 2016 Jul 24. Mol Cell Proteomics. 2016. PMID: 27452731 Free PMC article.
References
-
- American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277–304. - PubMed
-
- Travis WD, Hunninghake G, King TE, Jr, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier J-F, du Bois RM, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008;177:1338–1347. - PubMed
-
- Flaherty KR, King TE, Jr, Raghu G, Lynch JP, III, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170:904–910. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous